Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Acamprosate Calcium, and what generic Acamprosate Calcium alternatives are available?

Acamprosate Calcium is a drug marketed by Glenmark Generics, Mylan Pharms Inc, and Barr Labs Div Teva. and is included in three NDAs.

The generic ingredient in ACAMPROSATE CALCIUM is acamprosate calcium. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the acamprosate calcium profile page.

Summary for Tradename: ACAMPROSATE CALCIUM

Suppliers / Packagers: see list8
Bulk Api Vendors: see list39
Clinical Trials: see list746
Patent Applications: see list324
Formulation / Manufacturing:see details
Drug Prices:see details
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics
acamprosate calcium
TABLET, DELAYED RELEASE;ORAL202229-001Jul 16, 2013ABRXNoYes► Subscribe► Subscribe
Mylan Pharms Inc
acamprosate calcium
TABLET, DELAYED RELEASE;ORAL200142-001Mar 11, 2014ABRXNoNo► Subscribe► Subscribe
Barr Labs Div Teva
acamprosate calcium
TABLET, DELAYED RELEASE;ORAL200143-001Nov 18, 2013ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus